Atrium Biotech Usa Inc is categorized under Drugs, Proprietaries, and Sundries in Fairfield, NJ and active since 2010.
Atrium Biotech Usa Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Richard Bordeleau at the company’s single location by writing to 9 Commerce Road, Fairfield, New Jersey NJ 07004 or by phoning (973) 808-1400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Atrium Biotech Usa Inc |
| Contact Person: | Richard Bordeleau |
| Address: | 9 Commerce Road, Fairfield, New Jersey 07004 |
| Phone Number: | (973) 808-1400 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Atrium Biotech Usa Inc was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Bordeleau for inquiries that concern Atrium Biotech Usa Inc by calling the company number (973) 808-1400, as your correspondence is most welcome. Additionally, the physical location of the single location of Atrium Biotech Usa Inc can be found at the coordinates 40.871853,-74.316391 as well as the street address 9 Commerce Road in Fairfield, New Jersey 07004.
For its online presence, you may visit Atrium Biotech Usa Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.